2015
DOI: 10.1002/jps.24587
|View full text |Cite
|
Sign up to set email alerts
|

Fabrication, Physico-Chemical, and Pharmaceutical Characterization of Budesonide-Loaded Electrospun Fibers for Drug Targeting to the Colon

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(8 citation statements)
references
References 19 publications
1
5
0
2
Order By: Relevance
“…In fact, the presence of ES in the nanofiber structure even at the low levels caused drug protection in the simulated gastric medium. This finding was in agreemnt with the other investigations [37,38] in which ES prevented drug release in acidic pH from electrospun nanofibers comprising pantoprazole and budesonide. In another study working on 5-fluorouracil (5-FU) loaded fibers with ES shell, a rapid release in the acidic medium was reported and explained by the high acid solubility of the drug and also the low molecular weight of 5-FU which enabled drug diffusion through the pores in the polymer coating [39].…”
Section: In Vitro Release Studysupporting
confidence: 92%
“…In fact, the presence of ES in the nanofiber structure even at the low levels caused drug protection in the simulated gastric medium. This finding was in agreemnt with the other investigations [37,38] in which ES prevented drug release in acidic pH from electrospun nanofibers comprising pantoprazole and budesonide. In another study working on 5-fluorouracil (5-FU) loaded fibers with ES shell, a rapid release in the acidic medium was reported and explained by the high acid solubility of the drug and also the low molecular weight of 5-FU which enabled drug diffusion through the pores in the polymer coating [39].…”
Section: In Vitro Release Studysupporting
confidence: 92%
“…Likewise, electrospun fibers loaded with budesonide were prepared with the aim of controlling its release in the gastrointestinal tract using Eudragit RS 100, a polymer soluble at pH > 7, commonly used for enteric release of drugs. The dissolution rate measurements using a pH-change method showed low drug dissolution at pH 1.0 and sustained release at pH 7.2, representing an effective method for drug targeting to terminal ileum and colon with the aim of improving the local efficacy of budesonide for the treatment of some inflammatory bowel diseases [62]. Researchers have developed a novel core-shell-structured nanofilm for colon delivery by coaxial electrospinning using bovine serum albumin as protein model.…”
Section: Electrospinning In Colon-targeted Per Oral Drug Deliverymentioning
confidence: 99%
“…70 Budesonid glukokortikosteroid bir ilaçtır. İleum ve kolondaki inflamatuar barsak hastalıklarının tedavisinde çok etkilidir.…”
Section: Kolona öZgü İlaç Taşiyici Si̇stemlerunclassified